search
Back to results

iPeer2Peer Program for Youth With Sickle Cell Disease

Primary Purpose

Sickle Cell Disease

Status
Active
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
iPeer2Peer Mentorship
Sponsored by
The Hospital for Sick Children
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sickle Cell Disease

Eligibility Criteria

12 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 12-18 years old
  • Diagnosed with SCD by a haematologist
  • Able to speak and read English
  • Access to Internet connection with computer capable of using free Skype software
  • Willing and able to complete online measures.

Exclusion Criteria:

  • Significant cognitive impairments
  • Major co-morbid illnesses (medical or psychiatric conditions) likely to influence HRQoL assessment
  • Currently participating in other peer support or self-management interventions.

Sites / Locations

  • Connecticut Children's Medical Center
  • Children's Hospital of Eastern Ontario (CHEO)
  • The Hospital for Sick Children
  • Jim Pattison

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

iPeer2Peer Mentorship

Waitlist Control Group

Arm Description

In addition to standard care, participants in the experimental group will receive the iPeer2Peer program, a peer mentorship program that will provide modelling and reinforcement of self-management by pre-screened and trained peer mentors (young adults with SCD aged 19-25 who have learned to function successfully with their condition). Mentors will encourage participants to develop and engage in self-management skills and provide social support.

The control group participants will receive standard care and will be on a waitlist to receive the iPeer2Peer program until 15 weeks after completing their baseline questionnaires.

Outcomes

Primary Outcome Measures

Recruitment Rate
The number of participants recruited for the study during the recruitment study period.
Rates of completion of mentor-mentee calls
Compliance defined as 100% when a participant completes 10 calls within 15 weeks with their mentor
Withdrawal Rate
Number of participants that withdraw from the study over the study period
Acceptability of iPeer2Peer SCD intervention
Participants' perception regarding the acceptability of the SCD iP2P program and their level of engagement with the program (via a semi-structured interview).

Secondary Outcome Measures

Sickle Cell Disease Pain Burden Interview- Youth
7-item questionnaire, measuring pain burden
Sickle Cell Disease Self-Efficacy Scale
9-item questionnaire, measuring self-efficacy
PROMIS- Pediatric Peer Relationships 8a
8-item questionnaire, measuring social support from peers
PROMIS depressive symptoms - 8a
8-item questionnaire, measuring depression
PROMIS anxiety - 8a
8-item questionnaire, measuring anxiety
PROMIS Pain Interference - 8a
8-item questionnaire, measuring consequences of pain on relevant aspects of person's life.
PROMIS pain intensity - 1a
1-item questionnaire, measuring intensity of pain over the past week
Transition-Q
14-item questionnaire, measuring self-management

Full Information

First Posted
June 17, 2019
Last Updated
April 10, 2023
Sponsor
The Hospital for Sick Children
Collaborators
Children's Hospital of Eastern Ontario, Royal University Hospital Foundation, Connecticut Children's Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT03989986
Brief Title
iPeer2Peer Program for Youth With Sickle Cell Disease
Official Title
Peer-to-Peer (iP2P) Mentoring Program for Youth With Sickle Cell Disease: A Pilot Feasibility Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
January 1, 2020 (Actual)
Primary Completion Date
June 30, 2022 (Actual)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Hospital for Sick Children
Collaborators
Children's Hospital of Eastern Ontario, Royal University Hospital Foundation, Connecticut Children's Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The iPeer2Peer Sickle Cell Disease (SCD) study matches youth (12-18 years of age) with SCD to a mentor (trained young adult) who has learned to manage their SCD well, transitioned to adult care, and can support youth participants emotionally and socially. Participants will be randomly assigned one of two groups, either (1) The intervention group: Study group participants are matched with a mentor for 15 weeks, and are expected to have up to ten calls with one another; (2) The control group: This study group will be on a 15 week waitlist to receive a mentor. This study will first assess the feasibility of conducting this research with youth with SCD. Also, this study will assess the preliminary effectiveness of peer mentorship by comparing various health outcomes of the two study groups post-intervention.
Detailed Description
Sickle Cell Disease (SCD) is a disease affecting red blood cells, where severe pain can develop due to blockage of red blood cells. This the most common genetic blood disease in North America, affecting mostly people of African descent. This type of pain can affect many aspects of one's life, and one's quality of life. Young people with SCD experience pain as they grow from childhood to adulthood, and experience daily chronic pain. There are many negative consequences of SCD, such as anxiety, depression, poor sleep, high stress, and limited social and physical activity. Peer support is a form of support that can provide someone with emotional, informational and social support. Peer support is a promising way of delivering emotional support, while helping someone learn how to cope and manage their disease. This is especially important for chronic diseases such as SCD, because young people will have to learn how to cope and manage their condition while growing up, and for the rest of their lives. A new way to provide face-to-face peer support is through the use of a virtual program using Skype via the Internet (to maintain face-to-face contact between mentors and mentees). In this program, a young adult (a mentor) with a chronic disease is matched with a younger person living with the same disease (a mentee) online, through Skype. The mentors are nominated by their healthcare teams, and have successfully transitioned to adult care. They are trained to talk to young people about their disease and can give them some advice on how to manage, and grow up with the condition. This program has been tested with other groups with Juvenile Idiopathic Arthritis and Chronic Pain. A mentor and a mentee are matched for 15 weeks and are encouraged to have up to ten Skype calls together. The investigators do not know how well this program will work with young people with SCD. Therefore, the investigators would like to test out this program to see if it is feasible to conduct the iPeer2Peer SCD program in the future as a larger study with the SCD population. Feasibility will be measured through the following: (1) recruitment and withdrawal rates; (2) rate of completion of weekly calls; (3) rate of completion of baseline measures; (4) estimates of intervention effects on health outcomes to inform the calculation of an appropriate sample size for the future definitive multi-centred randomized controlled trial (RCT) and (5) participants' perception regarding the acceptability of the SCD iP2P program and their level of engagement with the program (via a semi-structured interview). Descriptive statistics will be used to describe the sample characteristics at baseline. Rates of accrual, drop out, compliance, and missing data with 95% confidence intervals will be calculated.To inform sample size calculations and data analysis feasibility for a larger trial, data will be analyzed as in a larger study, and estimates of variance will be calculated. Secondary analysis will be conducted using an intent-to-treat approach. If assumptions for parametric statistics are met, linear regression models will be used to test intervention effects on pain impact, social support, self-efficacy, adherence and HRQL outcomes using an analysis of covariance approach with post-intervention measures compared between groups using baseline scores as covariates. The semi-structured individual (mentees) and focus group (mentors) interviews will determine (i) mentees' acceptability of and level of engagement in the iP2P program and (ii) mentors' likes and dislikes of program, improvement. This data, and subsequent analyses, will be used to refine the iP2P program prior to a full trial. A larger study will help to understand if peer support delivered by a mentor over Skype will help teenagers with SCD better manage their SCD, improve their health outcomes, and ultimately improve their quality of life living with SCD.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sickle Cell Disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
28 (Actual)

8. Arms, Groups, and Interventions

Arm Title
iPeer2Peer Mentorship
Arm Type
Experimental
Arm Description
In addition to standard care, participants in the experimental group will receive the iPeer2Peer program, a peer mentorship program that will provide modelling and reinforcement of self-management by pre-screened and trained peer mentors (young adults with SCD aged 19-25 who have learned to function successfully with their condition). Mentors will encourage participants to develop and engage in self-management skills and provide social support.
Arm Title
Waitlist Control Group
Arm Type
No Intervention
Arm Description
The control group participants will receive standard care and will be on a waitlist to receive the iPeer2Peer program until 15 weeks after completing their baseline questionnaires.
Intervention Type
Behavioral
Intervention Name(s)
iPeer2Peer Mentorship
Intervention Description
Mentors and participants can have up to ten Skype calls over the course of 15 weeks.
Primary Outcome Measure Information:
Title
Recruitment Rate
Description
The number of participants recruited for the study during the recruitment study period.
Time Frame
2 years
Title
Rates of completion of mentor-mentee calls
Description
Compliance defined as 100% when a participant completes 10 calls within 15 weeks with their mentor
Time Frame
15 weeks
Title
Withdrawal Rate
Description
Number of participants that withdraw from the study over the study period
Time Frame
2 years
Title
Acceptability of iPeer2Peer SCD intervention
Description
Participants' perception regarding the acceptability of the SCD iP2P program and their level of engagement with the program (via a semi-structured interview).
Time Frame
15 weeks
Secondary Outcome Measure Information:
Title
Sickle Cell Disease Pain Burden Interview- Youth
Description
7-item questionnaire, measuring pain burden
Time Frame
Baseline and 15 weeks after baseline completion.
Title
Sickle Cell Disease Self-Efficacy Scale
Description
9-item questionnaire, measuring self-efficacy
Time Frame
Baseline and 15 weeks
Title
PROMIS- Pediatric Peer Relationships 8a
Description
8-item questionnaire, measuring social support from peers
Time Frame
Baseline and 15 weeks
Title
PROMIS depressive symptoms - 8a
Description
8-item questionnaire, measuring depression
Time Frame
Baseline and 15 weeks
Title
PROMIS anxiety - 8a
Description
8-item questionnaire, measuring anxiety
Time Frame
Baseline and 15 weeks
Title
PROMIS Pain Interference - 8a
Description
8-item questionnaire, measuring consequences of pain on relevant aspects of person's life.
Time Frame
Baseline and 15 weeks
Title
PROMIS pain intensity - 1a
Description
1-item questionnaire, measuring intensity of pain over the past week
Time Frame
Baseline and 15 weeks
Title
Transition-Q
Description
14-item questionnaire, measuring self-management
Time Frame
Baseline and 15 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 12-18 years old Diagnosed with SCD by a haematologist Able to speak and read English Access to Internet connection with computer capable of using free Skype software Willing and able to complete online measures. Exclusion Criteria: Significant cognitive impairments Major co-morbid illnesses (medical or psychiatric conditions) likely to influence HRQoL assessment Currently participating in other peer support or self-management interventions.
Facility Information:
Facility Name
Connecticut Children's Medical Center
City
Hartford
State/Province
Connecticut
ZIP/Postal Code
06106
Country
United States
Facility Name
Children's Hospital of Eastern Ontario (CHEO)
City
Ottawa
State/Province
Ontario
Country
Canada
Facility Name
The Hospital for Sick Children
City
Toronto
State/Province
Ontario
Country
Canada
Facility Name
Jim Pattison
City
Saskatoon
State/Province
Saskatchewan
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

iPeer2Peer Program for Youth With Sickle Cell Disease

We'll reach out to this number within 24 hrs